Evidence map›Paper›PMID 29997478›Full record

ReviewFrontiers in cellular neuroscience2018

Cortical GABAergic Interneuron/Progenitor Transplantation as a Novel Therapy for Intractable Epilepsy.

Qian Zhu, Janice R Naegele, Sangmi Chung

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. More than just summed neuronal activity: how multiple cell types shape the BOLD response.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Review
  12. mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Qian ZhuTranslational Stem Cell Neurobiology Laboratory, Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United States.
Janice R NaegeleHall-Atwater Laboratory, Department of Biology, Program in Neuroscience and Behavior, Wesleyan University, Middletown, CT, United States.
Sangmi ChungTranslational Stem Cell Neurobiology Laboratory, Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, United States.
New York Medical College · USWesleyan University · US

Funding

iPSC derived human cortical interneurons as developmental model of SchizophreniaR01MH107884 · NIMH · NEW YORK MEDICAL COLLEGE · PI CHUNG, SANGMI · 2015 to 2019
$2.2M
Stem Cell Transplantation for EpilepsyR15NS072879 · NINDS · WESLEYAN UNIVERSITY · PI NAEGELE, JANICE RAE · 2013 to 2013
$485k
NIMH NIH HHS R01 MH107884NINDS NIH HHS R15 NS072879
6 · The paper itself

Abstract

Epilepsy is a severe neurological disease affecting more than 70 million people worldwide that is characterized by unpredictable and abnormal electrical discharges resulting in recurrent seizures. Although antiepileptic drugs (AEDs) are the mainstay of epilepsy treatment for seizure control, about one third of patients with epilepsy suffer from intractable seizures that are unresponsive to AEDs. Furthermore, the patients that respond to AEDs typically experience adverse systemic side effects, underscoring the urgent need to develop new therapies that target epileptic foci rather than more systemic interventions. Neurosurgical removal of affected brain tissues or implanting neurostimulator devices are effective options only for a fraction of patients with drug-refractory seizures, so it is imperative to develop treatments that are more generally applicable and restorative in nature. Considering the abnormalities of GABAergic inhibitory interneurons in epileptic brain tissues, one strategy with considerable promise is to restore normal circuit function by transplanting GABAergic interneurons/progenitors into the seizure focus. In this review, we focus on recent studies of cortical GABAergic interneuron transplantation to treat epilepsy and discuss critical issues in moving this promising experimental therapeutic treatment into clinic.

Indexed as

animal modelscell transplantationdifferentiationGABAergic interneuronshuman pluripotent stem cellsintractable epilepsy

Identifiers

PMID29997478
PMCPMC6028694
OpenAlexW2806600150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.